nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunisolide—Growth retardation—Dactinomycin—muscle cancer	0.0668	0.0668	CcSEcCtD
Flunisolide—Ocular discomfort—Methotrexate—muscle cancer	0.029	0.029	CcSEcCtD
Flunisolide—Pleurisy—Methotrexate—muscle cancer	0.0269	0.0269	CcSEcCtD
Flunisolide—Numbness—Vincristine—muscle cancer	0.0163	0.0163	CcSEcCtD
Flunisolide—Sensory loss—Vincristine—muscle cancer	0.0156	0.0156	CcSEcCtD
Flunisolide—Numbness—Etoposide—muscle cancer	0.0132	0.0132	CcSEcCtD
Flunisolide—Sensory loss—Etoposide—muscle cancer	0.0127	0.0127	CcSEcCtD
Flunisolide—Chest discomfort—Etoposide—muscle cancer	0.0124	0.0124	CcSEcCtD
Flunisolide—Candida infection—Etoposide—muscle cancer	0.0105	0.0105	CcSEcCtD
Flunisolide—Oral candidiasis—Doxorubicin—muscle cancer	0.00896	0.00896	CcSEcCtD
Flunisolide—Pneumonia—Dactinomycin—muscle cancer	0.00853	0.00853	CcSEcCtD
Flunisolide—Hypokinesia—Doxorubicin—muscle cancer	0.00843	0.00843	CcSEcCtD
Flunisolide—Stomatitis—Dactinomycin—muscle cancer	0.00827	0.00827	CcSEcCtD
Flunisolide—Laryngitis—Doxorubicin—muscle cancer	0.0079	0.0079	CcSEcCtD
Flunisolide—Pneumonia—Vincristine—muscle cancer	0.00762	0.00762	CcSEcCtD
Flunisolide—Pharyngitis—Dactinomycin—muscle cancer	0.00756	0.00756	CcSEcCtD
Flunisolide—Stomatitis—Vincristine—muscle cancer	0.00739	0.00739	CcSEcCtD
Flunisolide—Sweating—Vincristine—muscle cancer	0.00727	0.00727	CcSEcCtD
Flunisolide—Erythema multiforme—Dactinomycin—muscle cancer	0.0072	0.0072	CcSEcCtD
Flunisolide—Glossitis—Methotrexate—muscle cancer	0.00713	0.00713	CcSEcCtD
Flunisolide—Ageusia—Doxorubicin—muscle cancer	0.00703	0.00703	CcSEcCtD
Flunisolide—Stinging—Doxorubicin—muscle cancer	0.00703	0.00703	CcSEcCtD
Flunisolide—Dysphonia—Doxorubicin—muscle cancer	0.00692	0.00692	CcSEcCtD
Flunisolide—Chills—Dactinomycin—muscle cancer	0.00683	0.00683	CcSEcCtD
Flunisolide—Bronchospasm—Etoposide—muscle cancer	0.00677	0.00677	CcSEcCtD
Flunisolide—Hypoaesthesia—Vincristine—muscle cancer	0.00677	0.00677	CcSEcCtD
Flunisolide—Vaginal inflammation—Methotrexate—muscle cancer	0.00658	0.00658	CcSEcCtD
Flunisolide—Cough increased—Doxorubicin—muscle cancer	0.00622	0.00622	CcSEcCtD
Flunisolide—Vaginal infection—Methotrexate—muscle cancer	0.00621	0.00621	CcSEcCtD
Flunisolide—Glossitis—Doxorubicin—muscle cancer	0.00618	0.00618	CcSEcCtD
Flunisolide—Lacrimation increased—Doxorubicin—muscle cancer	0.00618	0.00618	CcSEcCtD
Flunisolide—Pneumonia—Etoposide—muscle cancer	0.00618	0.00618	CcSEcCtD
Flunisolide—Ill-defined disorder—Dactinomycin—muscle cancer	0.00615	0.00615	CcSEcCtD
Flunisolide—Stomatitis—Etoposide—muscle cancer	0.00599	0.00599	CcSEcCtD
Flunisolide—Malaise—Dactinomycin—muscle cancer	0.00598	0.00598	CcSEcCtD
Flunisolide—Neck pain—Doxorubicin—muscle cancer	0.00576	0.00576	CcSEcCtD
Flunisolide—Back pain—Vincristine—muscle cancer	0.00573	0.00573	CcSEcCtD
Flunisolide—Vaginal inflammation—Doxorubicin—muscle cancer	0.00569	0.00569	CcSEcCtD
Flunisolide—Myalgia—Dactinomycin—muscle cancer	0.00564	0.00564	CcSEcCtD
Flunisolide—Lymphadenopathy—Methotrexate—muscle cancer	0.00559	0.00559	CcSEcCtD
Flunisolide—Discomfort—Dactinomycin—muscle cancer	0.00558	0.00558	CcSEcCtD
Flunisolide—Hypoaesthesia—Etoposide—muscle cancer	0.00548	0.00548	CcSEcCtD
Flunisolide—Agitation—Vincristine—muscle cancer	0.00544	0.00544	CcSEcCtD
Flunisolide—Candida infection—Doxorubicin—muscle cancer	0.00544	0.00544	CcSEcCtD
Flunisolide—Oedema—Dactinomycin—muscle cancer	0.00541	0.00541	CcSEcCtD
Flunisolide—Infection—Dactinomycin—muscle cancer	0.00538	0.00538	CcSEcCtD
Flunisolide—Vaginal infection—Doxorubicin—muscle cancer	0.00537	0.00537	CcSEcCtD
Flunisolide—Vertigo—Vincristine—muscle cancer	0.00532	0.00532	CcSEcCtD
Flunisolide—Erythema multiforme—Etoposide—muscle cancer	0.00521	0.00521	CcSEcCtD
Flunisolide—Hypertension—Vincristine—muscle cancer	0.00511	0.00511	CcSEcCtD
Flunisolide—Myalgia—Vincristine—muscle cancer	0.00504	0.00504	CcSEcCtD
Flunisolide—Chills—Etoposide—muscle cancer	0.00495	0.00495	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00493	0.00493	CcSEcCtD
Flunisolide—Lymphadenopathy—Doxorubicin—muscle cancer	0.00484	0.00484	CcSEcCtD
Flunisolide—Oedema—Vincristine—muscle cancer	0.00483	0.00483	CcSEcCtD
Flunisolide—Infection—Vincristine—muscle cancer	0.0048	0.0048	CcSEcCtD
Flunisolide—Decreased appetite—Dactinomycin—muscle cancer	0.0047	0.0047	CcSEcCtD
Flunisolide—Dysgeusia—Etoposide—muscle cancer	0.0047	0.0047	CcSEcCtD
Flunisolide—Hyperhidrosis—Vincristine—muscle cancer	0.00467	0.00467	CcSEcCtD
Flunisolide—Fatigue—Dactinomycin—muscle cancer	0.00467	0.00467	CcSEcCtD
Flunisolide—Back pain—Etoposide—muscle cancer	0.00464	0.00464	CcSEcCtD
Flunisolide—Pain—Dactinomycin—muscle cancer	0.00463	0.00463	CcSEcCtD
Flunisolide—Eczema—Doxorubicin—muscle cancer	0.0046	0.0046	CcSEcCtD
Flunisolide—Irritability—Methotrexate—muscle cancer	0.00456	0.00456	CcSEcCtD
Flunisolide—Feeling abnormal—Dactinomycin—muscle cancer	0.00446	0.00446	CcSEcCtD
Flunisolide—Ill-defined disorder—Etoposide—muscle cancer	0.00445	0.00445	CcSEcCtD
Flunisolide—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00442	0.00442	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Vincristine—muscle cancer	0.0044	0.0044	CcSEcCtD
Flunisolide—Increased appetite—Doxorubicin—muscle cancer	0.0044	0.0044	CcSEcCtD
Flunisolide—Insomnia—Vincristine—muscle cancer	0.00437	0.00437	CcSEcCtD
Flunisolide—Malaise—Etoposide—muscle cancer	0.00433	0.00433	CcSEcCtD
Flunisolide—Vertigo—Etoposide—muscle cancer	0.00431	0.00431	CcSEcCtD
Flunisolide—Abdominal pain—Dactinomycin—muscle cancer	0.00428	0.00428	CcSEcCtD
Flunisolide—Body temperature increased—Dactinomycin—muscle cancer	0.00428	0.00428	CcSEcCtD
Flunisolide—Loss of consciousness—Etoposide—muscle cancer	0.00422	0.00422	CcSEcCtD
Flunisolide—Decreased appetite—Vincristine—muscle cancer	0.0042	0.0042	CcSEcCtD
Flunisolide—Cough—Etoposide—muscle cancer	0.00419	0.00419	CcSEcCtD
Flunisolide—Fatigue—Vincristine—muscle cancer	0.00417	0.00417	CcSEcCtD
Flunisolide—Hypertension—Etoposide—muscle cancer	0.00414	0.00414	CcSEcCtD
Flunisolide—Pain—Vincristine—muscle cancer	0.00413	0.00413	CcSEcCtD
Flunisolide—Constipation—Vincristine—muscle cancer	0.00413	0.00413	CcSEcCtD
Flunisolide—Chest pain—Etoposide—muscle cancer	0.00409	0.00409	CcSEcCtD
Flunisolide—Migraine—Doxorubicin—muscle cancer	0.00407	0.00407	CcSEcCtD
Flunisolide—Discomfort—Etoposide—muscle cancer	0.00404	0.00404	CcSEcCtD
Flunisolide—Hypersensitivity—Dactinomycin—muscle cancer	0.00399	0.00399	CcSEcCtD
Flunisolide—Abdominal discomfort—Methotrexate—muscle cancer	0.00395	0.00395	CcSEcCtD
Flunisolide—Gastrointestinal pain—Vincristine—muscle cancer	0.00395	0.00395	CcSEcCtD
Flunisolide—Infection—Etoposide—muscle cancer	0.00389	0.00389	CcSEcCtD
Flunisolide—Asthenia—Dactinomycin—muscle cancer	0.00388	0.00388	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00383	0.00383	CcSEcCtD
Flunisolide—Tachycardia—Etoposide—muscle cancer	0.00382	0.00382	CcSEcCtD
Flunisolide—Abdominal pain—Vincristine—muscle cancer	0.00382	0.00382	CcSEcCtD
Flunisolide—Body temperature increased—Vincristine—muscle cancer	0.00382	0.00382	CcSEcCtD
Flunisolide—Hyperhidrosis—Etoposide—muscle cancer	0.00379	0.00379	CcSEcCtD
Flunisolide—Diarrhoea—Dactinomycin—muscle cancer	0.0037	0.0037	CcSEcCtD
Flunisolide—Pneumonia—Methotrexate—muscle cancer	0.0037	0.0037	CcSEcCtD
Flunisolide—Nasopharyngitis—Doxorubicin—muscle cancer	0.0037	0.0037	CcSEcCtD
Flunisolide—Abdominal distension—Doxorubicin—muscle cancer	0.0036	0.0036	CcSEcCtD
Flunisolide—Stomatitis—Methotrexate—muscle cancer	0.00359	0.00359	CcSEcCtD
Flunisolide—Conjunctivitis—Methotrexate—muscle cancer	0.00358	0.00358	CcSEcCtD
Flunisolide—Hypersensitivity—Vincristine—muscle cancer	0.00356	0.00356	CcSEcCtD
Flunisolide—Sweating—Methotrexate—muscle cancer	0.00353	0.00353	CcSEcCtD
Flunisolide—Dyspnoea—Etoposide—muscle cancer	0.00349	0.00349	CcSEcCtD
Flunisolide—Epistaxis—Methotrexate—muscle cancer	0.00347	0.00347	CcSEcCtD
Flunisolide—Asthenia—Vincristine—muscle cancer	0.00347	0.00347	CcSEcCtD
Flunisolide—Vomiting—Dactinomycin—muscle cancer	0.00344	0.00344	CcSEcCtD
Flunisolide—Bronchitis—Doxorubicin—muscle cancer	0.00344	0.00344	CcSEcCtD
Flunisolide—Rash—Dactinomycin—muscle cancer	0.00341	0.00341	CcSEcCtD
Flunisolide—Decreased appetite—Etoposide—muscle cancer	0.0034	0.0034	CcSEcCtD
Flunisolide—Fatigue—Etoposide—muscle cancer	0.00338	0.00338	CcSEcCtD
Flunisolide—Constipation—Etoposide—muscle cancer	0.00335	0.00335	CcSEcCtD
Flunisolide—Pain—Etoposide—muscle cancer	0.00335	0.00335	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00332	0.00332	CcSEcCtD
Flunisolide—Diarrhoea—Vincristine—muscle cancer	0.00331	0.00331	CcSEcCtD
Flunisolide—Pharyngitis—Methotrexate—muscle cancer	0.00328	0.00328	CcSEcCtD
Flunisolide—Weight increased—Doxorubicin—muscle cancer	0.00325	0.00325	CcSEcCtD
Flunisolide—Feeling abnormal—Etoposide—muscle cancer	0.00323	0.00323	CcSEcCtD
Flunisolide—Nausea—Dactinomycin—muscle cancer	0.00321	0.00321	CcSEcCtD
Flunisolide—Pneumonia—Doxorubicin—muscle cancer	0.0032	0.0032	CcSEcCtD
Flunisolide—Gastrointestinal pain—Etoposide—muscle cancer	0.0032	0.0032	CcSEcCtD
Flunisolide—Dizziness—Vincristine—muscle cancer	0.0032	0.0032	CcSEcCtD
Flunisolide—Erythema multiforme—Methotrexate—muscle cancer	0.00312	0.00312	CcSEcCtD
Flunisolide—Urticaria—Etoposide—muscle cancer	0.00311	0.00311	CcSEcCtD
Flunisolide—Stomatitis—Doxorubicin—muscle cancer	0.0031	0.0031	CcSEcCtD
Flunisolide—Abdominal pain—Etoposide—muscle cancer	0.0031	0.0031	CcSEcCtD
Flunisolide—Body temperature increased—Etoposide—muscle cancer	0.0031	0.0031	CcSEcCtD
Flunisolide—Conjunctivitis—Doxorubicin—muscle cancer	0.0031	0.0031	CcSEcCtD
Flunisolide—Urinary tract infection—Doxorubicin—muscle cancer	0.0031	0.0031	CcSEcCtD
Flunisolide—Vomiting—Vincristine—muscle cancer	0.00307	0.00307	CcSEcCtD
Flunisolide—Sweating—Doxorubicin—muscle cancer	0.00305	0.00305	CcSEcCtD
Flunisolide—Rash—Vincristine—muscle cancer	0.00305	0.00305	CcSEcCtD
Flunisolide—Dermatitis—Vincristine—muscle cancer	0.00305	0.00305	CcSEcCtD
Flunisolide—Headache—Vincristine—muscle cancer	0.00303	0.00303	CcSEcCtD
Flunisolide—Epistaxis—Doxorubicin—muscle cancer	0.003	0.003	CcSEcCtD
Flunisolide—Sinusitis—Doxorubicin—muscle cancer	0.00299	0.00299	CcSEcCtD
Flunisolide—Chills—Methotrexate—muscle cancer	0.00296	0.00296	CcSEcCtD
Flunisolide—Hypersensitivity—Etoposide—muscle cancer	0.00289	0.00289	CcSEcCtD
Flunisolide—Malnutrition—Methotrexate—muscle cancer	0.00287	0.00287	CcSEcCtD
Flunisolide—Nausea—Vincristine—muscle cancer	0.00287	0.00287	CcSEcCtD
Flunisolide—Rhinitis—Doxorubicin—muscle cancer	0.00287	0.00287	CcSEcCtD
Flunisolide—Hypoaesthesia—Doxorubicin—muscle cancer	0.00284	0.00284	CcSEcCtD
Flunisolide—Pharyngitis—Doxorubicin—muscle cancer	0.00284	0.00284	CcSEcCtD
Flunisolide—Oedema peripheral—Doxorubicin—muscle cancer	0.00282	0.00282	CcSEcCtD
Flunisolide—Dysgeusia—Methotrexate—muscle cancer	0.00281	0.00281	CcSEcCtD
Flunisolide—Asthenia—Etoposide—muscle cancer	0.00281	0.00281	CcSEcCtD
Flunisolide—Back pain—Methotrexate—muscle cancer	0.00278	0.00278	CcSEcCtD
Flunisolide—Pruritus—Etoposide—muscle cancer	0.00277	0.00277	CcSEcCtD
Flunisolide—Vision blurred—Methotrexate—muscle cancer	0.00271	0.00271	CcSEcCtD
Flunisolide—Erythema multiforme—Doxorubicin—muscle cancer	0.0027	0.0027	CcSEcCtD
Flunisolide—Diarrhoea—Etoposide—muscle cancer	0.00268	0.00268	CcSEcCtD
Flunisolide—Ill-defined disorder—Methotrexate—muscle cancer	0.00267	0.00267	CcSEcCtD
Flunisolide—Malaise—Methotrexate—muscle cancer	0.00259	0.00259	CcSEcCtD
Flunisolide—Dizziness—Etoposide—muscle cancer	0.00259	0.00259	CcSEcCtD
Flunisolide—Vertigo—Methotrexate—muscle cancer	0.00258	0.00258	CcSEcCtD
Flunisolide—Chills—Doxorubicin—muscle cancer	0.00257	0.00257	CcSEcCtD
Flunisolide—Cough—Methotrexate—muscle cancer	0.00251	0.00251	CcSEcCtD
Flunisolide—Vomiting—Etoposide—muscle cancer	0.00249	0.00249	CcSEcCtD
Flunisolide—Malnutrition—Doxorubicin—muscle cancer	0.00249	0.00249	CcSEcCtD
Flunisolide—Rash—Etoposide—muscle cancer	0.00247	0.00247	CcSEcCtD
Flunisolide—Dermatitis—Etoposide—muscle cancer	0.00247	0.00247	CcSEcCtD
Flunisolide—Headache—Etoposide—muscle cancer	0.00245	0.00245	CcSEcCtD
Flunisolide—Myalgia—Methotrexate—muscle cancer	0.00245	0.00245	CcSEcCtD
Flunisolide—Chest pain—Methotrexate—muscle cancer	0.00245	0.00245	CcSEcCtD
Flunisolide—Dysgeusia—Doxorubicin—muscle cancer	0.00244	0.00244	CcSEcCtD
Flunisolide—Discomfort—Methotrexate—muscle cancer	0.00242	0.00242	CcSEcCtD
Flunisolide—Back pain—Doxorubicin—muscle cancer	0.00241	0.00241	CcSEcCtD
Flunisolide—Vision blurred—Doxorubicin—muscle cancer	0.00235	0.00235	CcSEcCtD
Flunisolide—Infection—Methotrexate—muscle cancer	0.00233	0.00233	CcSEcCtD
Flunisolide—Nausea—Etoposide—muscle cancer	0.00233	0.00233	CcSEcCtD
Flunisolide—Ill-defined disorder—Doxorubicin—muscle cancer	0.00231	0.00231	CcSEcCtD
Flunisolide—Agitation—Doxorubicin—muscle cancer	0.00229	0.00229	CcSEcCtD
Flunisolide—Hyperhidrosis—Methotrexate—muscle cancer	0.00227	0.00227	CcSEcCtD
Flunisolide—Malaise—Doxorubicin—muscle cancer	0.00224	0.00224	CcSEcCtD
Flunisolide—Vertigo—Doxorubicin—muscle cancer	0.00224	0.00224	CcSEcCtD
Flunisolide—Syncope—Doxorubicin—muscle cancer	0.00223	0.00223	CcSEcCtD
Flunisolide—Palpitations—Doxorubicin—muscle cancer	0.0022	0.0022	CcSEcCtD
Flunisolide—Loss of consciousness—Doxorubicin—muscle cancer	0.00219	0.00219	CcSEcCtD
Flunisolide—Cough—Doxorubicin—muscle cancer	0.00217	0.00217	CcSEcCtD
Flunisolide—Hypertension—Doxorubicin—muscle cancer	0.00215	0.00215	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00214	0.00214	CcSEcCtD
Flunisolide—Insomnia—Methotrexate—muscle cancer	0.00212	0.00212	CcSEcCtD
Flunisolide—Myalgia—Doxorubicin—muscle cancer	0.00212	0.00212	CcSEcCtD
Flunisolide—Chest pain—Doxorubicin—muscle cancer	0.00212	0.00212	CcSEcCtD
Flunisolide—Anxiety—Doxorubicin—muscle cancer	0.00211	0.00211	CcSEcCtD
Flunisolide—Discomfort—Doxorubicin—muscle cancer	0.00209	0.00209	CcSEcCtD
Flunisolide—Dyspnoea—Methotrexate—muscle cancer	0.00209	0.00209	CcSEcCtD
Flunisolide—Dyspepsia—Methotrexate—muscle cancer	0.00206	0.00206	CcSEcCtD
Flunisolide—Decreased appetite—Methotrexate—muscle cancer	0.00204	0.00204	CcSEcCtD
Flunisolide—Oedema—Doxorubicin—muscle cancer	0.00203	0.00203	CcSEcCtD
Flunisolide—Fatigue—Methotrexate—muscle cancer	0.00202	0.00202	CcSEcCtD
Flunisolide—Infection—Doxorubicin—muscle cancer	0.00202	0.00202	CcSEcCtD
Flunisolide—Pain—Methotrexate—muscle cancer	0.00201	0.00201	CcSEcCtD
Flunisolide—Shock—Doxorubicin—muscle cancer	0.002	0.002	CcSEcCtD
Flunisolide—Tachycardia—Doxorubicin—muscle cancer	0.00198	0.00198	CcSEcCtD
Flunisolide—Hyperhidrosis—Doxorubicin—muscle cancer	0.00196	0.00196	CcSEcCtD
Flunisolide—Feeling abnormal—Methotrexate—muscle cancer	0.00193	0.00193	CcSEcCtD
Flunisolide—Gastrointestinal pain—Methotrexate—muscle cancer	0.00192	0.00192	CcSEcCtD
Flunisolide—Urticaria—Methotrexate—muscle cancer	0.00186	0.00186	CcSEcCtD
Flunisolide—Body temperature increased—Methotrexate—muscle cancer	0.00185	0.00185	CcSEcCtD
Flunisolide—Abdominal pain—Methotrexate—muscle cancer	0.00185	0.00185	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00185	0.00185	CcSEcCtD
Flunisolide—Insomnia—Doxorubicin—muscle cancer	0.00184	0.00184	CcSEcCtD
Flunisolide—Dyspnoea—Doxorubicin—muscle cancer	0.00181	0.00181	CcSEcCtD
Flunisolide—Dyspepsia—Doxorubicin—muscle cancer	0.00179	0.00179	CcSEcCtD
Flunisolide—Decreased appetite—Doxorubicin—muscle cancer	0.00177	0.00177	CcSEcCtD
Flunisolide—Fatigue—Doxorubicin—muscle cancer	0.00175	0.00175	CcSEcCtD
Flunisolide—Constipation—Doxorubicin—muscle cancer	0.00174	0.00174	CcSEcCtD
Flunisolide—Pain—Doxorubicin—muscle cancer	0.00174	0.00174	CcSEcCtD
Flunisolide—Hypersensitivity—Methotrexate—muscle cancer	0.00173	0.00173	CcSEcCtD
Flunisolide—Asthenia—Methotrexate—muscle cancer	0.00168	0.00168	CcSEcCtD
Flunisolide—Feeling abnormal—Doxorubicin—muscle cancer	0.00167	0.00167	CcSEcCtD
Flunisolide—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00166	0.00166	CcSEcCtD
Flunisolide—Pruritus—Methotrexate—muscle cancer	0.00166	0.00166	CcSEcCtD
Flunisolide—Urticaria—Doxorubicin—muscle cancer	0.00161	0.00161	CcSEcCtD
Flunisolide—Body temperature increased—Doxorubicin—muscle cancer	0.00161	0.00161	CcSEcCtD
Flunisolide—Abdominal pain—Doxorubicin—muscle cancer	0.00161	0.00161	CcSEcCtD
Flunisolide—Diarrhoea—Methotrexate—muscle cancer	0.0016	0.0016	CcSEcCtD
Flunisolide—Dizziness—Methotrexate—muscle cancer	0.00155	0.00155	CcSEcCtD
Flunisolide—Hypersensitivity—Doxorubicin—muscle cancer	0.0015	0.0015	CcSEcCtD
Flunisolide—Vomiting—Methotrexate—muscle cancer	0.00149	0.00149	CcSEcCtD
Flunisolide—Rash—Methotrexate—muscle cancer	0.00148	0.00148	CcSEcCtD
Flunisolide—Dermatitis—Methotrexate—muscle cancer	0.00148	0.00148	CcSEcCtD
Flunisolide—Headache—Methotrexate—muscle cancer	0.00147	0.00147	CcSEcCtD
Flunisolide—Asthenia—Doxorubicin—muscle cancer	0.00146	0.00146	CcSEcCtD
Flunisolide—Pruritus—Doxorubicin—muscle cancer	0.00144	0.00144	CcSEcCtD
Flunisolide—Nausea—Methotrexate—muscle cancer	0.00139	0.00139	CcSEcCtD
Flunisolide—Diarrhoea—Doxorubicin—muscle cancer	0.00139	0.00139	CcSEcCtD
Flunisolide—Dizziness—Doxorubicin—muscle cancer	0.00134	0.00134	CcSEcCtD
Flunisolide—Vomiting—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Flunisolide—Rash—Doxorubicin—muscle cancer	0.00128	0.00128	CcSEcCtD
Flunisolide—Dermatitis—Doxorubicin—muscle cancer	0.00128	0.00128	CcSEcCtD
Flunisolide—Headache—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
Flunisolide—Nausea—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
